Immunohistochemistry of the tumor tissue revealed a significant reduction in E6 oncoprotein levels, vascular endothelial growth factor (VEGF), and proliferating cellular nuclear antigen (PCNA) of 79%, 60.5%, and 75.5%, respectively. This evidence concerns the gene VEGFA and neoplasm.